287 related articles for article (PubMed ID: 26607930)
21. Advances in adjuvant therapy of biliary tract cancer: an overview of current clinical evidence based on phase II and III trials.
Belkouz A; Wilmink JW; Haj Mohammad N; Hagendoorn J; de Vos-Geelen J; Dejong CHC; Homs MYV; Groot Koerkamp B; van Gulik TM; van Oijen MGH; Punt CJA; Klümpen H
Crit Rev Oncol Hematol; 2020 Jul; 151():102975. PubMed ID: 32464483
[TBL] [Abstract][Full Text] [Related]
22. Genomic Profiling of Biliary Tract Cancers and Implications for Clinical Practice.
Jain A; Kwong LN; Javle M
Curr Treat Options Oncol; 2016 Nov; 17(11):58. PubMed ID: 27658789
[TBL] [Abstract][Full Text] [Related]
23. Increased incidence but improved median overall survival for biliary tract cancers diagnosed in Ontario from 1994 through 2012: A population-based study.
Flemming JA; Zhang-Salomons J; Nanji S; Booth CM
Cancer; 2016 Aug; 122(16):2534-43. PubMed ID: 27183133
[TBL] [Abstract][Full Text] [Related]
24. Immunotherapeutic Approaches to Biliary Cancer.
Shah UA; Nandikolla AG; Rajdev L
Curr Treat Options Oncol; 2017 Jul; 18(7):44. PubMed ID: 28660602
[TBL] [Abstract][Full Text] [Related]
25. The Hepatobiliary and Pancreatic Oncology (HBPO) Group of the Japan Clinical Oncology Group (JCOG): history and future direction.
Furuse J; Ishii H; Okusaka T
Jpn J Clin Oncol; 2013 Jan; 43(1):2-7. PubMed ID: 23100604
[TBL] [Abstract][Full Text] [Related]
26. SEOM clinical guidelines in metastatic breast cancer 2015.
Gavilá J; Lopez-Tarruella S; Saura C; Muñoz M; Oliveira M; De la Cruz-Merino L; Morales S; Alvarez I; Virizuela JA; Martin M
Clin Transl Oncol; 2015 Dec; 17(12):946-55. PubMed ID: 26683474
[TBL] [Abstract][Full Text] [Related]
27. Multimodality Management of Localized Biliary Cancer.
Ashai N; Prasad P; Rajdev L
Curr Treat Options Oncol; 2019 May; 20(7):58. PubMed ID: 31144050
[TBL] [Abstract][Full Text] [Related]
28. Role of adjuvant and neoadjuvant therapy for resectable biliary tract cancer.
Nara S; Esaki M; Ban D; Takamoto T; Mizui T; Shimada K
Expert Rev Gastroenterol Hepatol; 2021 May; 15(5):537-545. PubMed ID: 33793366
[No Abstract] [Full Text] [Related]
29. Immunotherapy of biliary tract cancer.
Chai Y
Tumour Biol; 2016 Mar; 37(3):2817-21. PubMed ID: 26729196
[TBL] [Abstract][Full Text] [Related]
30. Diagnosis and treatment update: cholangiocarcinoma.
Wijaya I; Abdullah M
Acta Med Indones; 2011 Jul; 43(3):212-5. PubMed ID: 21979289
[TBL] [Abstract][Full Text] [Related]
31. Adjuvant therapy for resected biliary tract cancer: a review.
Doherty MK; Knox JJ
Chin Clin Oncol; 2016 Oct; 5(5):64. PubMed ID: 27701873
[TBL] [Abstract][Full Text] [Related]
32. Pitfalls, challenges, and updates in adjuvant systemic treatment for resected biliary tract cancer.
Rizzo A; Brandi G
Expert Rev Gastroenterol Hepatol; 2021 May; 15(5):547-554. PubMed ID: 33571059
[No Abstract] [Full Text] [Related]
33. Prognosis and Adherence with the National Comprehensive Cancer Network Guidelines of Patients with Biliary Tract Cancers: an Analysis of the National Cancer Database.
Bagante F; Gani F; Beal EW; Merath K; Chen Q; Dillhoff M; Cloyd J; Pawlik TM
J Gastrointest Surg; 2019 Mar; 23(3):518-528. PubMed ID: 30112703
[TBL] [Abstract][Full Text] [Related]
34. Biliary Cancer: Current Multimodality Treatment and Future Directions.
Copur MS; Merani S; Vargas LM
Oncology (Williston Park); 2019 Sep; 33(9):. PubMed ID: 31571182
[TBL] [Abstract][Full Text] [Related]
35. Adjuvant Therapy for Biliary Tract Cancers.
Horgan AM; Knox JJ
J Oncol Pract; 2018 Dec; 14(12):701-708. PubMed ID: 30537458
[TBL] [Abstract][Full Text] [Related]
36. Toward personalized treatment of advanced biliary tract cancers.
Geynisman DM; Catenacci DV
Discov Med; 2012 Jul; 14(74):41-57. PubMed ID: 22846202
[TBL] [Abstract][Full Text] [Related]
37. Updates in Gastrointestinal Oncology - insights from the 2008 44th annual meeting of the American Society of Clinical Oncology.
Javle M; Hsueh CT
J Hematol Oncol; 2009 Feb; 2():9. PubMed ID: 19236713
[TBL] [Abstract][Full Text] [Related]
38. Diagnosis and treatment of cholangiocarcinoma.
Anderson CD; Pinson CW; Berlin J; Chari RS
Oncologist; 2004; 9(1):43-57. PubMed ID: 14755014
[TBL] [Abstract][Full Text] [Related]
39. The use of imaging in the diagnosis and staging of hepatobiliary malignancies.
Miller G; Schwartz LH; D'Angelica M
Surg Oncol Clin N Am; 2007 Apr; 16(2):343-68. PubMed ID: 17560517
[TBL] [Abstract][Full Text] [Related]
40. Defining the role of adjuvant therapy: cholangiocarcinoma and gall bladder cancer.
Williams TM; Majithia L; Wang SJ; Thomas CR
Semin Radiat Oncol; 2014 Apr; 24(2):94-104. PubMed ID: 24635866
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
